Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta to Expand Sales Territories, Rebrands Lead Cancer Diagnostic

Premium

Rosetta Genomics this week announced that it plans to expand its US commercial operations from five sales territories to 12 next month.

The company also said that it has rebranded its flagship microRNA-based diagnostic MiRview Mets2, which is designed to identify the source of cancers of unknown primary origin, as the Rosetta Cancer Origin test.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.